Second 2018 Dividend and New Target Dividend Policy THE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
65
Second 2018 Dividend and New Target Dividend Policy

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

NB Private Equity Partners Announces its Second 2018 Dividend and Announces New Target Dividend Policy

19 July 2018

Second 2018 Dividend

NB Private Equity Partners Limited ("NBPE" or the "Company"), a closed-end private equity investment company, today declared the second 2018 semi-annual dividend payment on the Company's class A Ordinary Shares ("Shares") of $0.28 per Share, to be paid on 31 August 2018. This dividend is a $0.03 increase from the Company's prior dividend payment.1 On an annualised basis, this dividend payment represents a dividend yield of 4.1% based on the London Stock Exchange closing price of £10.50 ($13.70 at GBP/USD exchange rate of $1.305) on 18 July 2018.

NBPE also announces a target dividend policy as a further enhancement of its ongoing policy of returning capital to shareholders. NBPE intends to target an annualised dividend yield of 3.0% or greater on NAV and plans to continue to make semi-annual payments to shareholders. This dividend yield is a target only, is subject to available capacity and is not guaranteed.

The dividend is payable from income and realisations and is approximately 4.8x covered based on 30 June 2018 YTD cash distributions to NBPE of approximately $131 million.2 While the Company declares dividends in US Dollars, Shareholders will receive Sterling at the prevailing rate at the time of currency conversion, unless an election to receive dividends in US Dollars is made on forms which are available on NBPE's website prior to the currency election date listed below. If an investor has previously elected to receive US Dollars, that election will be used unless changed. Investors who seek capital gains rather than income also have the option of participating in a dividend re-investment plan, forms of which are available on NBPE's website.

Dividend Timetable

Distribution amount: $0.28 cents per Share
Ex-dividend date: 26 July 2018
Dividend record date: 27 July 2018
Final day for Currency Election: 3 August 2018
Final day for Dividend Re-investment Plan Election3: 10 August 2018
Payment date: 31 August 2018
  1. This dividend as well as future dividends shall be conditional on the passing of the solvency test under Guernsey law. The Board of Directors will continue to evaluate the Company's financial position, annual dividend amounts and the timing of future dividends. Future dividend payments will be announced by NBPE after the Board of Directors have completed such evaluation.
  2. The above distribution guidance regarding investment portfolio performance is not a profit forecast. There can be no assurance that this distribution level will be sustained or that the Company will make any distributions whatsoever. The times and dates in this announcement are expected times and dates only and are subject to change. Any such changes will be notified to shareholders through a regulatory information service.
  3. Anyone acting for the account or benefit of a U.S. person who elects to receive additional shares through the dividend re-investment plan would need to sign a Qualified Purchaser certification, which is available from the Company's Investor Relations upon request by contacting +1 214 647 9593 or IR_NBPE@nb.com.

For further information, please contact:

NBPE Investor Relations          +1 214 647 9593             Neustria Partners                     +44 20 3021 2580 Nick Henderson                         Nick.Henderson@neustriapartners.com Robert Bailhache                       Robert.Bailhache@neustriapartners.com Charles Gorman                        Charles.Gorman@neustriapartners.com

ABOUT NB PRIVATE EQUITY PARTNERS LIMITED NBPE is a closed-end private equity investment company with class A ordinary shares admitted to trading on the Premium Segment of the Main Market of the London Stock Exchange and Euronext Amsterdam. NBPE has 2022 and 2024 ZDP Shares admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange. NBPE holds a diversified portfolio of direct equity investments, direct income investments and fund investments selected by the NB Alternatives group of Neuberger Berman, diversified across private equity asset class, geography, industry, vintage year, and sponsor.

LEI number: 213800UJH93NH8IOFQ77

ABOUT NEUBERGER BERMAN

Neuberger Berman, founded in 1939, is a private, independent, employee-owned investment manager. The firm manages a range of strategies-including equity, fixed income, quantitative and multi-asset class, private equity and hedge funds-on behalf of institutions, advisors and individual investors globally. With offices in 20 countries, Neuberger Berman's team is more than 2,000 professionals. For four consecutive years, the company has been named first or second in Pensions & Investments Best Places to Work in Money Management survey (among those with 1,000 employees or more). Tenured, stable and long-term in focus, the firm fosters an investment culture of fundamental research and independent thinking. It manages $304 billion in client assets as of June 30, 2018. For more information, please visit our website at www.nb.com.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security.

NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. NBPE is registered with the Dutch Authority for the Financial Markets as a collective investment scheme which may offer participations in The Netherlands pursuant to article 2:66 of the Financial Markets Supervision Act (Wet op het financial toezicht). All investments are subject to risk. Past performance is no guarantee of future returns. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE's investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains "forward-looking statements." Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 4

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
Automotive ECU Market Aims $160B by 2033

Updated Category News Views 0

Automotive ECUs Under the Spotlight Picture this: By 2033, the automotive ECU market is expected to balloon to a whopping $160.59 billion. That's some serious cash, and it ain't just pocket change. This $47 billion jump from 2026 isn't just happening by accident—it's got everything to do with high-octane changes in the industry. With a 5.1% CAGR, you best believe it's a...

Continue Reading
Rznomics Unveils Breakthrough in Circular RNA Production

Updated Category News Views 1

Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...

Continue Reading
BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 2

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 3

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 2

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 5

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 3

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
KuCoin's KCUSD Tackles Stablecoin Idle Capital Problem

Updated Category News Views 0

KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...

Continue Reading

Top 5 Most Recently Viewed Articles

STMicroelectronics Leadership Changes As Company Faces Challenges

Updated Category News Views 277

Leadership Changes at STMicroelectronics Italy is contemplating a significant shift in leadership at STMicroelectronics as concerns about the company's direction and performance have surfaced. The Italian government is mulling over the possibility of replacing CEO Jean-Marc Chéry in light of perceived inadequate results, especially as the semiconductor industry continues...

Continue Reading
Empowering Young Minds with Tricoci University’s New Beauty Program

Updated Category News Views 397

Introducing Tricoci Forward: A New Initiative for Aspiring Beauticians Tricoci University of Beauty Culture is thrilled to unveil Tricoci Forward, a groundbreaking program aimed at inspiring high school students interested in the beauty industry. This initiative not only welcomes budding talents but also cultivates an environment where creativity and ambition can...

Continue Reading
Enhancements in ezPaycheck to Meet New Tax Regulations

Updated Category News Views 108

New Features in ezPaycheck for Enhanced Compliance The recent updates in ezPaycheck are here to support businesses in adapting to the changing landscape of tax regulations following the enactment of The One Big Beautiful Bill. This update comes as a critical resource that empowers small and mid-sized businesses, accountants, and payroll processors to remain compliant with...

Continue Reading
Unicycive Therapeutics: Upcoming Investor Conferences Insights

Updated Category News Views 191

Unicycive Therapeutics and Their Upcoming Appearances Unicycive Therapeutics, Inc., a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies for kidney disease, is poised to make a significant impact at two upcoming investment conferences. The company's Chief Executive Officer, Shalabh Gupta, M.D., will engage with investors, sharing...

Continue Reading
Unlocking the Potential of Algae: A Sustainable Nutritional Shift

Updated Category News Views 119

The Surging Algae Products Market: A Sustainable Alternative The algae products market is experiencing remarkable growth, showcasing its potential to transform nutrition and wellness. Originally considered a niche, algae have emerged as a key player in food, health, beauty, and pharmaceuticals. With a valuation projected to rise significantly, the market is anticipated to...

Continue Reading